Literature DB >> 18782046

Synthesis and biological evaluation of naphthalene-1,4-dione derivatives as potent antimycobacterial agents.

A Mital1, V S Negi, U Ramachandran.   

Abstract

The recent increase in the incidence of tuberculosis with the emergence of multi-drug resistant (MDR) cases has lead to the search for new drugs that are effective against MDR strains of Mycobacterium tuberculosis (M. tb) and can augment the potential of existing drugs against tuberculosis. In the present study a series of naphthalene-1,4-dione derivatives were synthesized and evaluated for their in vitro antimycobacterial activity against M. tb H37Rv strain. Preliminary results indicated that most of the compounds demonstrated significant antimycobacterial activities. The most effective compounds of the series 7, 8 and 10 have MIC values of 3.13 microg/mL and growth inhibition of 99%. Compound 7 has an IC50 value of 0.49 microg/mL. Compounds 1, 3 and 18 with MIC values of 3.13 microg/mL also showed 96-98% growth inhibition. The objective of our study is to generate new leads through different mode of action and to optimize their structure to display the potent efficacy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782046     DOI: 10.2174/157340608785700243

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  2 in total

1.  A novel naphthoquinone derivative shows selective antifungal activity against Sporothrix yeasts and biofilms.

Authors:  Luana P Borba-Santos; Caroline Deckmann Nicoletti; Taissa Vila; Patricia Garcia Ferreira; Carlos Fernando Araújo-Lima; Bárbara Verena Dias Galvão; Israel Felzenszwalb; Wanderley de Souza; Fernando de Carvalho da Silva; Vitor Francisco Ferreira; Debora Omena Futuro; Sonia Rozental
Journal:  Braz J Microbiol       Date:  2022-03-08       Impact factor: 2.214

2.  Evaluating novel synthetic compounds active against Bacillus subtilis and Bacillus cereus spores using Live imaging with SporeTrackerX.

Authors:  Soraya Omardien; Alexander Ter Beek; Norbert Vischer; Roy Montijn; Frank Schuren; Stanley Brul
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.